BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 30608296)

  • 1. Mohs Micrographic Surgery: Past, Present, and Future.
    Cohen DK; Goldberg DJ
    Dermatol Surg; 2019 Mar; 45(3):329-339. PubMed ID: 30608296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mohs micrographic surgery: established uses and emerging trends.
    Pennington BE; Leffell DJ
    Oncology (Williston Park); 2005 Aug; 19(9):1165-71; discussion 1171-2, 1175. PubMed ID: 16255133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mohs micrographic surgery for melanoma: A prospective multicenter study.
    Ellison PM; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.
    Gloster HM; Harris KR; Roenigk RK
    J Am Acad Dermatol; 1996 Jul; 35(1):82-7. PubMed ID: 8682970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs micrographic surgery: a treatment method for many non-melanocytic skin cancers.
    Dokic Y; Nguyen QL; Orengo I
    Dermatol Online J; 2020 Apr; 26(4):. PubMed ID: 32621679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
    Stigall LE; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
    Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
    Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review on the Role of Paraffin-embedded Margin-controlled Mohs Micrographic Surgery to Treat Skin Tumors.
    Mansilla-Polo M; Morgado-Carrasco D; Toll A
    Actas Dermosifiliogr; 2024 Jun; 115(6):T555-T571. PubMed ID: 38648936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review on the Role of Paraffin-embedded Margin-controlled Mohs Micrographic Surgery to Treat Skin Tumors.
    Mansilla-Polo M; Morgado-Carrasco D; Toll A
    Actas Dermosifiliogr; 2024 Jun; 115(6):555-571. PubMed ID: 38395222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
    Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
    JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
    Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
    Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery and the otolaryngologist.
    Stein JM; Hrabovsky S; Schuller DE; Siegle RJ
    Am J Otolaryngol; 2004; 25(6):385-93. PubMed ID: 15547806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
    Thomas CJ; Wood GC; Marks VJ
    Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excision of selected skin tumours using Mohs' micrographic surgery with horizontal paraffin-embedded sections.
    Barlow RJ; Ramnarain N; Smith N; Mayou B; Markey AC; Walker NP
    Br J Dermatol; 1996 Dec; 135(6):911-7. PubMed ID: 8977711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
    Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
    J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Recurrence of periumbilical Paget disease after fresh Mohs treated with slow Mohs with CK-7.
    Ferández IS; Buceta LR; Del Real CM; Gijón RC
    Dermatol Online J; 2011 Jul; 17(7):13. PubMed ID: 21810398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mohs micrographic surgery for digital melanoma and nonmelanoma skin cancers.
    Husain Z; Allawh RM; Hendi A
    Cutis; 2018 May; 101(5):346-352. PubMed ID: 29894522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
    Zabielinski M; Leithauser L; Godsey T; Gloster HM
    Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
    Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
    Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.